Paul Tudor Jones Ocugen, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Ocugen, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 13,865 shares of OCGN stock, worth $9,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,865
Previous 13,865
-0.0%
Holding current value
$9,012
Previous $13,000
15.38%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding OCGN
# of Institutions
123Shares Held
68.6MCall Options Held
478KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$11.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.6MShares$10.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.59MShares$4.28 Million0.0% of portfolio
-
State Street Corp Boston, MA5.87MShares$3.81 Million0.0% of portfolio
-
Gmt Capital Corp Atlanta, GA2.45MShares$1.6 Million0.1% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $141M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...